Your session is about to expire
← Back to Search
Communication and Adherence Intervention for Breast Cancer (SIS Trial)
SIS Trial Summary
This trial will test a new way to help Black women stick to their systemic therapy, which is the main treatment for breast cancer.
SIS Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSIS Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.SIS Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I haven't had cancer treatment in the last 2 years, except for skin cancer.I am capable of understanding and consenting to participate in the study.I am eligible for, but have not started, chemotherapy or hormone therapy.I was recently diagnosed with cancer (stage I-III) and have not started treatment.
- Group 1: Sisters Informing Sisters Sessions
- Group 2: Enhanced Usual Care
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there opportunities for enrolling participants in this trial?
"Affirmative. Clinicaltrials.gov documents that, following its initial posting on March 1st 2021 and most recent review April 20th 2022, this clinical trial is currently recruiting participants - with 460 people needed from two distinct locations."
How many participants are participating in this medical trial at the present time?
"That is correct. According to records posted on clinicaltrials.gov, this medical trial was initially launched in March 2021 and last modified in April 2022. 460 participants must be recruited from two different research sites for the study to continue its progress."
What aim is this experiment seeking to fulfill?
"This study, taking place over 36 months, aims to evaluate participants' adherence behaviors as they start the trial. Secondary objectives include measuring patient and doctor engagement via a Perceived Involvement in Care (PCC) 13-Item scale during audiotaped medical encounters. This assessment will be used to differentiate between more biomedically focused versus patient-centered care."
Share this study with friends
Copy Link
Messenger